Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Another stent study

This article was originally published in The Gray Sheet

Executive Summary

Data from 2,449 "unselected," real-world coronary stent patients at Wake Forest University Baptist Medical Center suggests that drug-eluting stents are associated with fewer acute myocardial infarctions and deaths than bare-metal stents at nine-month follow-up. The single-center observational study, published in the Feb. 1 American Journal of Cardiology, compared propensity score-adjusted adverse event rates from 1,164 bare-metal stent patients treated in the year before FDA approved drug-eluting stents (April 2002 to April 2003) and 1,285 comparable patients treated with drug-eluting stents from February 2004 to April 2005. The acute myocardial infarction rate for drug-eluting stents was 3.7% versus 4.7% for bare metal; likewise, the death rate was 4.9% versus 7.1%, and the target vessel revascularization rate was 2.8% versus 8.6%. The study was sponsored by Boston Scientific and Johnson & Johnson/Cordis. Drug-eluting stents have gone from being used in almost 90% of U.S. stenting procedures to around 75% since last summer over concerns about higher rates of thrombosis...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT024473

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel